← Back to opportunities
grant
National Institutes of Health

Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)

Source: grants.gov CFDA: Status: posted Lifecycle: modified

Eligibility

See opportunity for details

Similar opportunities